This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Agilent Announces Receipt of FDA Approval for pharmDX Assay
by Zacks Equity Research
Agilent (A) receives approval on the expanded use of its PD-L1 IHC 22C3 pharmDx assay.
What Makes Amtek (AME) a New Buy Stock
by Zacks Equity Research
Amtek (AME) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Why Is Amtek (AME) Down 3.7% Since Last Earnings Report?
by Zacks Equity Research
Amtek (AME) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks.com featured highlights include: Verint Systems, Comcast, Popular, CACI International and AMETEK
by Zacks Equity Research
Zacks.com featured highlights include: Verint Systems, Comcast, Popular, CACI International and AMETEK
5 High-Flying Stocks Near 52-Week High That Can Scale Higher
by Zacks Equity Research
Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have a high chance of carrying the momentum forward.
Top Ranked Momentum Stocks to Buy for May 7th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 7th.
Amtek (AME) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Amtek (AME) have what it takes to be a top stock pick for momentum investors? Let's find out.
Amtek (AME) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Amtek (AME) delivered earnings and revenue surprises of 3.09% and 1.09%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
AMETEK (AME) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
AMETEK's (AME) first-quarter 2019 results benefit from solid organic growth and positive contributions from acquisitions.
Amtek (AME) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Amtek (AME) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
What's in Store for AMETEK (AME) This Earnings Season?
by Zacks Equity Research
AMETEK's (AME) first-quarter results are likely to benefit from positive contributions from acquisitions.
TE Connectivity's (TEL) Q2 Earnings & Revenues Top Estimates
by Zacks Equity Research
TE Connectivity (TEL) second-quarter fiscal 2018 results benefit from strong performance of its Industrial Solutions segment.
Amtek (AME) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Amtek (AME) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Texas Instruments (TXN) Q1 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Texas Instruments' (TXN) first-quarter 2019 results benefit from manufacturing strategies and strong performance in communications equipment space. However, weak demand environment hurt the top line.
Zacks.com featured expert Kevin Matras highlights: Verint Systems, CACI International, Xilinx, Tech Data and AMETEK
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Verint Systems, CACI International, Xilinx, Tech Data and AMETEK
Waters' (WAT) Earnings and Revenues Miss Estimates in Q1
by Zacks Equity Research
Waters' (WAT) first-quarter 2019 results were negatively impacted by sluggish customer spending and macro-economic headwinds.
5 Fundamentally Sound High-Flying Stocks to Scale Higher
by Zacks Equity Research
Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have a high chance of carrying the momentum forward.
Are You Looking for a Top Momentum Pick? Why Amtek (AME) is a Great Choice
by Zacks Equity Research
Does Amtek (AME) have what it takes to be a top stock pick for momentum investors? Let's find out.
Amtek (AME) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Amtek (AME) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Amtek (AME) Stock Moves 0.89%: What You Should Know
by Zacks Equity Research
In the latest trading session, Amtek (AME) closed at $84.79, marking a +0.89% move from the previous day.
Amtek (AME) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Amtek (AME) closed the most recent trading day at $84.28, moving +0.32% from the previous trading session.
Zacks.com featured highlights include: Verint, Fortinet, CACI, AMETEK and Xilinx
by Zacks Equity Research
Zacks.com featured highlights include: Verint, Fortinet, CACI, AMETEK and Xilinx
5 High-Flying Stocks Near 52-Week High That Can Scale Higher
by Zacks Equity Research
Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have a high chance of carrying the momentum forward.
Cypress Announces Closure of JV With SK Hynix System
by Zacks Equity Research
Cypress (CY) has recently closed its JV with SK hynix system.
The Zacks Analyst Blog Highlights: Hilton, Abercrombie & Fitch, AMETEK, Ralph Lauren and Spirit
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Hilton, Abercrombie & Fitch, AMETEK, Ralph Lauren and Spirit